Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,815
archived clinical trials in
Parkinsons Disease

Use of Zolpidem in Parkinson's Disease
A Randomized, Controlled, Double-Blind, Cross-over Study of Zolpidem for Patients With Parkinson's Disease
Status: Enrolling
Updated:  5/9/2011
Rush University Medical Center
1730
mi
from 98109
Chicago, IL
Use of Zolpidem in Parkinson's Disease
A Randomized, Controlled, Double-Blind, Cross-over Study of Zolpidem for Patients With Parkinson's Disease
Status: Enrolling
Updated: 5/9/2011
Rush University Medical Center
1730
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
PRISM Registry: Pseudobulbar Affect Registry Series
PRISM Registry: Pseudobulbar Affect Registry Series
Status: Enrolling
Updated:  6/2/2011
Avanir Pharmaceuticals
1001
mi
from 98109
Aliso Viejo, CA
PRISM Registry: Pseudobulbar Affect Registry Series
PRISM Registry: Pseudobulbar Affect Registry Series
Status: Enrolling
Updated: 6/2/2011
Avanir Pharmaceuticals
1001
mi
from 98109
Aliso Viejo, CA
Click here to add this to my saved trials
Development of an Instrumented System to Measure Mobility in Parkinson's Disease
Development of an Instrumented System to Measure Mobility in Parkinson's Disease
Status: Enrolling
Updated:  6/24/2011
Oregon Clinical Translational Research Institute
149
mi
from 98109
Portland, OR
Development of an Instrumented System to Measure Mobility in Parkinson's Disease
Development of an Instrumented System to Measure Mobility in Parkinson's Disease
Status: Enrolling
Updated: 6/24/2011
Oregon Clinical Translational Research Institute
149
mi
from 98109
Portland, OR
Click here to add this to my saved trials
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated:  7/4/2011
University of Southern California
962
mi
from 98109
Los Angeles, CA
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated: 7/4/2011
University of Southern California
962
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated:  7/4/2011
Eastern Connecticut Neurology Specialists, LLC
2436
mi
from 98109
Manchester, CT
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated: 7/4/2011
Eastern Connecticut Neurology Specialists, LLC
2436
mi
from 98109
Manchester, CT
Click here to add this to my saved trials
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated:  7/4/2011
The Institute for Neurodegenerative Disorders
2432
mi
from 98109
New Haven, CT
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated: 7/4/2011
The Institute for Neurodegenerative Disorders
2432
mi
from 98109
New Haven, CT
Click here to add this to my saved trials
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated:  7/4/2011
Parkinson's Disease and Movement Disorders Center of Boca Raton
2707
mi
from 98109
Boca Raton, FL
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated: 7/4/2011
Parkinson's Disease and Movement Disorders Center of Boca Raton
2707
mi
from 98109
Boca Raton, FL
Click here to add this to my saved trials
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated:  7/4/2011
Rush University Medical Center
1730
mi
from 98109
Chicago, IL
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated: 7/4/2011
Rush University Medical Center
1730
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated:  7/4/2011
Ochsner Medical Center
2095
mi
from 98109
New Orleans, LA
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated: 7/4/2011
Ochsner Medical Center
2095
mi
from 98109
New Orleans, LA
Click here to add this to my saved trials
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated:  7/4/2011
Massachusetts General Hospital
2485
mi
from 98109
Boston, MA
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated: 7/4/2011
Massachusetts General Hospital
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated:  7/4/2011
Boston University Medical Center
2485
mi
from 98109
Boston, MA
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated: 7/4/2011
Boston University Medical Center
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated:  7/4/2011
Michigan State University
1855
mi
from 98109
East Lansing, MI
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated: 7/4/2011
Michigan State University
1855
mi
from 98109
East Lansing, MI
Click here to add this to my saved trials
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated:  7/4/2011
Struthers Parkinson's Center
1386
mi
from 98109
Golden Valley, MN
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated: 7/4/2011
Struthers Parkinson's Center
1386
mi
from 98109
Golden Valley, MN
Click here to add this to my saved trials
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated:  7/4/2011
Mt. Sinai Medical Center
2402
mi
from 98109
New York, NY
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated: 7/4/2011
Mt. Sinai Medical Center
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated:  7/4/2011
Duke University School of Medicine
2341
mi
from 98109
Durham, NC
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated: 7/4/2011
Duke University School of Medicine
2341
mi
from 98109
Durham, NC
Click here to add this to my saved trials
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated:  7/4/2011
University of Cincinnati
1967
mi
from 98109
Cincinnati, OH
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated: 7/4/2011
University of Cincinnati
1967
mi
from 98109
Cincinnati, OH
Click here to add this to my saved trials
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated:  7/4/2011
Cleveland Clinic
2024
mi
from 98109
Cleveland, OH
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated: 7/4/2011
Cleveland Clinic
2024
mi
from 98109
Cleveland, OH
Click here to add this to my saved trials
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated:  7/4/2011
Oregon Health and Science University
147
mi
from 98109
Portland, OR
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated: 7/4/2011
Oregon Health and Science University
147
mi
from 98109
Portland, OR
Click here to add this to my saved trials
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated:  7/4/2011
Butler Hospital Movement Disorder Program
2486
mi
from 98109
Providence, RI
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated: 7/4/2011
Butler Hospital Movement Disorder Program
2486
mi
from 98109
Providence, RI
Click here to add this to my saved trials
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated:  7/4/2011
Scott & White Hospital
1740
mi
from 98109
Temple, TX
Safety of Urate Elevation in Parkinson's Disease
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease
Status: Enrolling
Updated: 7/4/2011
Scott & White Hospital
1740
mi
from 98109
Temple, TX
Click here to add this to my saved trials
Validation of Dyskinesia Rating Scales
Validation of Dyskinesia Rating Scales
Status: Enrolling
Updated:  7/20/2011
University of Alabama-Birmingham (UAB)
2072
mi
from 98109
Birmingham, AL
Validation of Dyskinesia Rating Scales
Validation of Dyskinesia Rating Scales
Status: Enrolling
Updated: 7/20/2011
University of Alabama-Birmingham (UAB)
2072
mi
from 98109
Birmingham, AL
Click here to add this to my saved trials
Validation of Dyskinesia Rating Scales
Validation of Dyskinesia Rating Scales
Status: Enrolling
Updated:  7/20/2011
University of South Florida
2523
mi
from 98109
Tampa, FL
Validation of Dyskinesia Rating Scales
Validation of Dyskinesia Rating Scales
Status: Enrolling
Updated: 7/20/2011
University of South Florida
2523
mi
from 98109
Tampa, FL
Click here to add this to my saved trials
Validation of Dyskinesia Rating Scales
Validation of Dyskinesia Rating Scales
Status: Enrolling
Updated:  7/20/2011
Rush University Medical Center
1730
mi
from 98109
Chicago, IL
Validation of Dyskinesia Rating Scales
Validation of Dyskinesia Rating Scales
Status: Enrolling
Updated: 7/20/2011
Rush University Medical Center
1730
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Validation of Dyskinesia Rating Scales
Validation of Dyskinesia Rating Scales
Status: Enrolling
Updated:  7/20/2011
Duke University
2341
mi
from 98109
Durham, NC
Validation of Dyskinesia Rating Scales
Validation of Dyskinesia Rating Scales
Status: Enrolling
Updated: 7/20/2011
Duke University
2341
mi
from 98109
Durham, NC
Click here to add this to my saved trials
Validation of Dyskinesia Rating Scales
Validation of Dyskinesia Rating Scales
Status: Enrolling
Updated:  7/20/2011
Oregon Health & Science University (OHSU)
149
mi
from 98109
Portland, OR
Validation of Dyskinesia Rating Scales
Validation of Dyskinesia Rating Scales
Status: Enrolling
Updated: 7/20/2011
Oregon Health & Science University (OHSU)
149
mi
from 98109
Portland, OR
Click here to add this to my saved trials
The Effect of Exercise on Individuals With Parkinson's Disease
The Effect of Exercise on Individuals With Parkinson's Disease
Status: Enrolling
Updated:  8/9/2011
Clinical Motor Control Laboratory at the University of Illinois at Chicago
1730
mi
from 98109
Chicago, IL
The Effect of Exercise on Individuals With Parkinson's Disease
The Effect of Exercise on Individuals With Parkinson's Disease
Status: Enrolling
Updated: 8/9/2011
Clinical Motor Control Laboratory at the University of Illinois at Chicago
1730
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup—A Pilot Descriptive Study
Status: Archived
Updated:  12/12/2011
Cleveland Clinic Lou Ruvo Center for Brain Health
872
mi
from 98109
Las Vegas, NV
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup—A Pilot Descriptive Study
Status: Archived
Updated: 12/12/2011
Cleveland Clinic Lou Ruvo Center for Brain Health
872
mi
from 98109
Las Vegas, NV
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup—A Pilot Descriptive Study
Status: Archived
Updated:  12/12/2011
Cleveland Clinic Center for Brain Health - Mellen Center
2020
mi
from 98109
Cleveland, OH
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup—A Pilot Descriptive Study
Status: Archived
Updated: 12/12/2011
Cleveland Clinic Center for Brain Health - Mellen Center
2020
mi
from 98109
Cleveland, OH
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup—A Pilot Descriptive Study
Status: Archived
Updated:  12/12/2011
Cleveland Clinic Senior Care Assessment - Lakewood Hospital
2017
mi
from 98109
Lakewood, OH
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup—A Pilot Descriptive Study
Status: Archived
Updated: 12/12/2011
Cleveland Clinic Senior Care Assessment - Lakewood Hospital
2017
mi
from 98109
Lakewood, OH
The Effect of Donepezil on Gait and Balance in Parkinson's Disease
A Randomized, Double-blind, Placebo Controlled, Crossover Study to Evaluate the Effect of Donepezil on Gait and Balance in Parkinson's Disease
Status: Enrolling
Updated:  1/25/2012
Parkinson's Center of Oregon - Oregon Health and Science University
147
mi
from 98109
Portland, OR
The Effect of Donepezil on Gait and Balance in Parkinson's Disease
A Randomized, Double-blind, Placebo Controlled, Crossover Study to Evaluate the Effect of Donepezil on Gait and Balance in Parkinson's Disease
Status: Enrolling
Updated: 1/25/2012
Parkinson's Center of Oregon - Oregon Health and Science University
147
mi
from 98109
Portland, OR
Click here to add this to my saved trials
Structured Physical Activity for Sleep Quality and Daytime Sleepiness in Patients With Parkinson's Disease
Effect of a Structured Physical Activity Program on Sleep Quality and Sleepiness in Parkinson's Disease
Status: Enrolling
Updated:  2/28/2012
Northwestern University
1733
mi
from 98109
Chicago, IL
Structured Physical Activity for Sleep Quality and Daytime Sleepiness in Patients With Parkinson's Disease
Effect of a Structured Physical Activity Program on Sleep Quality and Sleepiness in Parkinson's Disease
Status: Enrolling
Updated: 2/28/2012
Northwestern University
1733
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Study to Assess Droxidopa in the Treatment of Freezing Of Gait Symptoms in Patients With Parkinson's Disease
A Phase II, Double-Blind, Placebo-Controlled Randomized Crossover Study to Assess the Clinical Benefit and Safety of Droxidopa in the Treatment of Freezing of Gait Symptoms in Patients With Parkinson's Disease
Status: Enrolling
Updated:  3/6/2012
Henry Ford West Bloomfield Hospital
1912
mi
from 98109
West Bloomfield, MI
Study to Assess Droxidopa in the Treatment of Freezing Of Gait Symptoms in Patients With Parkinson's Disease
A Phase II, Double-Blind, Placebo-Controlled Randomized Crossover Study to Assess the Clinical Benefit and Safety of Droxidopa in the Treatment of Freezing of Gait Symptoms in Patients With Parkinson's Disease
Status: Enrolling
Updated: 3/6/2012
Henry Ford West Bloomfield Hospital
1912
mi
from 98109
West Bloomfield, MI
Click here to add this to my saved trials
The ParkCycle Study
The ParkCycle Study: Effects of Aerobic Exercise on Cognitive and Adaptive Plasticity in Parkinson's Disease
Status: Enrolling
Updated:  3/22/2012
Cleveland Clinic
2024
mi
from 98109
Cleveland, OH
The ParkCycle Study
The ParkCycle Study: Effects of Aerobic Exercise on Cognitive and Adaptive Plasticity in Parkinson's Disease
Status: Enrolling
Updated: 3/22/2012
Cleveland Clinic
2024
mi
from 98109
Cleveland, OH
Click here to add this to my saved trials
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
A Phase 2, Randomized, Open-Label, Crossover Study to Compare DM-1992, a Novel Gastric-Retentive Extended-Release Formulation of Levodopa/Carbidopa, to an Immediate-Release Carbidopa Tablet in Patients With Advanced Parkinson's Disease With Motor Fluctuations
Status: Archived
Updated:  4/3/2012
Clinical Research Facility
2079
mi
from 98109
Birmingham, AL
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
A Phase 2, Randomized, Open-Label, Crossover Study to Compare DM-1992, a Novel Gastric-Retentive Extended-Release Formulation of Levodopa/Carbidopa, to an Immediate-Release Carbidopa Tablet in Patients With Advanced Parkinson's Disease With Motor Fluctuations
Status: Archived
Updated: 4/3/2012
Clinical Research Facility
2079
mi
from 98109
Birmingham, AL
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
A Phase 2, Randomized, Open-Label, Crossover Study to Compare DM-1992, a Novel Gastric-Retentive Extended-Release Formulation of Levodopa/Carbidopa, to an Immediate-Release Carbidopa Tablet in Patients With Advanced Parkinson's Disease With Motor Fluctuations
Status: Archived
Updated:  4/3/2012
Clinical Research Facility
1660
mi
from 98109
Fort Smith, AR
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
A Phase 2, Randomized, Open-Label, Crossover Study to Compare DM-1992, a Novel Gastric-Retentive Extended-Release Formulation of Levodopa/Carbidopa, to an Immediate-Release Carbidopa Tablet in Patients With Advanced Parkinson's Disease With Motor Fluctuations
Status: Archived
Updated: 4/3/2012
Clinical Research Facility
1660
mi
from 98109
Fort Smith, AR
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
A Phase 2, Randomized, Open-Label, Crossover Study to Compare DM-1992, a Novel Gastric-Retentive Extended-Release Formulation of Levodopa/Carbidopa, to an Immediate-Release Carbidopa Tablet in Patients With Advanced Parkinson's Disease With Motor Fluctuations
Status: Archived
Updated:  4/3/2012
Clinical Research Facility
710
mi
from 98109
Santa Clara, CA
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
A Phase 2, Randomized, Open-Label, Crossover Study to Compare DM-1992, a Novel Gastric-Retentive Extended-Release Formulation of Levodopa/Carbidopa, to an Immediate-Release Carbidopa Tablet in Patients With Advanced Parkinson's Disease With Motor Fluctuations
Status: Archived
Updated: 4/3/2012
Clinical Research Facility
710
mi
from 98109
Santa Clara, CA
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
A Phase 2, Randomized, Open-Label, Crossover Study to Compare DM-1992, a Novel Gastric-Retentive Extended-Release Formulation of Levodopa/Carbidopa, to an Immediate-Release Carbidopa Tablet in Patients With Advanced Parkinson's Disease With Motor Fluctuations
Status: Archived
Updated:  4/3/2012
Clinical Research Facility
2529
mi
from 98109
Daytona Beach, FL
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
A Phase 2, Randomized, Open-Label, Crossover Study to Compare DM-1992, a Novel Gastric-Retentive Extended-Release Formulation of Levodopa/Carbidopa, to an Immediate-Release Carbidopa Tablet in Patients With Advanced Parkinson's Disease With Motor Fluctuations
Status: Archived
Updated: 4/3/2012
Clinical Research Facility
2529
mi
from 98109
Daytona Beach, FL
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
A Phase 2, Randomized, Open-Label, Crossover Study to Compare DM-1992, a Novel Gastric-Retentive Extended-Release Formulation of Levodopa/Carbidopa, to an Immediate-Release Carbidopa Tablet in Patients With Advanced Parkinson's Disease With Motor Fluctuations
Status: Archived
Updated:  4/3/2012
Clinical Research Facility
1719
mi
from 98109
Park Ridge, IL
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
A Phase 2, Randomized, Open-Label, Crossover Study to Compare DM-1992, a Novel Gastric-Retentive Extended-Release Formulation of Levodopa/Carbidopa, to an Immediate-Release Carbidopa Tablet in Patients With Advanced Parkinson's Disease With Motor Fluctuations
Status: Archived
Updated: 4/3/2012
Clinical Research Facility
1719
mi
from 98109
Park Ridge, IL
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
A Phase 2, Randomized, Open-Label, Crossover Study to Compare DM-1992, a Novel Gastric-Retentive Extended-Release Formulation of Levodopa/Carbidopa, to an Immediate-Release Carbidopa Tablet in Patients With Advanced Parkinson's Disease With Motor Fluctuations
Status: Archived
Updated:  4/3/2012
Clinical Research Facility
1903
mi
from 98109
Ann Arbor, MI
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
A Phase 2, Randomized, Open-Label, Crossover Study to Compare DM-1992, a Novel Gastric-Retentive Extended-Release Formulation of Levodopa/Carbidopa, to an Immediate-Release Carbidopa Tablet in Patients With Advanced Parkinson's Disease With Motor Fluctuations
Status: Archived
Updated: 4/3/2012
Clinical Research Facility
1903
mi
from 98109
Ann Arbor, MI
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
A Phase 2, Randomized, Open-Label, Crossover Study to Compare DM-1992, a Novel Gastric-Retentive Extended-Release Formulation of Levodopa/Carbidopa, to an Immediate-Release Carbidopa Tablet in Patients With Advanced Parkinson's Disease With Motor Fluctuations
Status: Archived
Updated:  4/3/2012
Clinical Research Facility
2020
mi
from 98109
Cleveland, OH
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
A Phase 2, Randomized, Open-Label, Crossover Study to Compare DM-1992, a Novel Gastric-Retentive Extended-Release Formulation of Levodopa/Carbidopa, to an Immediate-Release Carbidopa Tablet in Patients With Advanced Parkinson's Disease With Motor Fluctuations
Status: Archived
Updated: 4/3/2012
Clinical Research Facility
2020
mi
from 98109
Cleveland, OH
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
A Phase 2, Randomized, Open-Label, Crossover Study to Compare DM-1992, a Novel Gastric-Retentive Extended-Release Formulation of Levodopa/Carbidopa, to an Immediate-Release Carbidopa Tablet in Patients With Advanced Parkinson's Disease With Motor Fluctuations
Status: Archived
Updated:  4/3/2012
Clinical Research Facility
1682
mi
from 98109
Dallas, TX
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
A Phase 2, Randomized, Open-Label, Crossover Study to Compare DM-1992, a Novel Gastric-Retentive Extended-Release Formulation of Levodopa/Carbidopa, to an Immediate-Release Carbidopa Tablet in Patients With Advanced Parkinson's Disease With Motor Fluctuations
Status: Archived
Updated: 4/3/2012
Clinical Research Facility
1682
mi
from 98109
Dallas, TX
Behavioral Treatments for Anxiety and Depression in Veterans With Parkinson's Disease
Increasing Access and Implementation of Behavioral Treatments for Anxiety and Depression in Rural Veterans With Parkinson's Disease
Status: Enrolling
Updated:  4/20/2012
Michael E. DeBakey Veteran Affairs Medical Center
1890
mi
from 98109
Houston, TX
Behavioral Treatments for Anxiety and Depression in Veterans With Parkinson's Disease
Increasing Access and Implementation of Behavioral Treatments for Anxiety and Depression in Rural Veterans With Parkinson's Disease
Status: Enrolling
Updated: 4/20/2012
Michael E. DeBakey Veteran Affairs Medical Center
1890
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Psychosocial Treatment of Depression in Parkinson's Disease
Psychosocial Treatment of Depression in Parkinson's Disease
Status: Enrolling
Updated:  5/2/2012
Massachusetts General Hospital
2485
mi
from 98109
Boston, MA
Psychosocial Treatment of Depression in Parkinson's Disease
Psychosocial Treatment of Depression in Parkinson's Disease
Status: Enrolling
Updated: 5/2/2012
Massachusetts General Hospital
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
Status: Enrolling
Updated:  5/25/2012
Clinical Research Facility
2322
mi
from 98109
Washington,
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
Status: Enrolling
Updated: 5/25/2012
Clinical Research Facility
2322
mi
from 98109
Washington,
Click here to add this to my saved trials
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
Status: Enrolling
Updated:  5/25/2012
Clinical Research Facility
1719
mi
from 98109
Park Ridge, IL
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
Status: Enrolling
Updated: 5/25/2012
Clinical Research Facility
1719
mi
from 98109
Park Ridge, IL
Click here to add this to my saved trials
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
Status: Enrolling
Updated:  5/25/2012
Clinical Research Facility
2083
mi
from 98109
Chattanooga, TN
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
Status: Enrolling
Updated: 5/25/2012
Clinical Research Facility
2083
mi
from 98109
Chattanooga, TN
Click here to add this to my saved trials
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
Status: Enrolling
Updated:  5/25/2012
Clinical Research Facility
1682
mi
from 98109
Dallas, TX
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
Status: Enrolling
Updated: 5/25/2012
Clinical Research Facility
1682
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
Local Field Potentials Recorded From Deep Brain Stimulating (DBS) Electrodes
Local Field Potentials Recorded From Deep Brain Stimulating Electrodes Implanted for the Treatment of Parkinson's Disease
Status: Enrolling
Updated:  6/21/2012
Department of Neurosurgery, University of Minnesota
1391
mi
from 98109
Minneapolis, MN
Local Field Potentials Recorded From Deep Brain Stimulating (DBS) Electrodes
Local Field Potentials Recorded From Deep Brain Stimulating Electrodes Implanted for the Treatment of Parkinson's Disease
Status: Enrolling
Updated: 6/21/2012
Department of Neurosurgery, University of Minnesota
1391
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated:  7/18/2012
Neurology Neurodiagnostic Lab
2091
mi
from 98109
Alabaster, AL
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated: 7/18/2012
Neurology Neurodiagnostic Lab
2091
mi
from 98109
Alabaster, AL
Click here to add this to my saved trials
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated:  7/18/2012
Neurological Physicians of Arizona
1129
mi
from 98109
Gilbert, AZ
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
A Multi-center, Double-blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Clinical Effect of Droxidopa in the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Status: Enrolling
Updated: 7/18/2012
Neurological Physicians of Arizona
1129
mi
from 98109
Gilbert, AZ
Click here to add this to my saved trials